Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer Discovery Analysis Demonstrates Transformative Sensitivity of 95% ...
Discovery Analysis Demonstrates Transformative Sensitivity of 95% with Specificity of 98% for the Detection of Pancreatic ...
Phase 3 AURORA trial of Descartes-08 in myasthenia gravis on track to commence in 1H25; Deep and durable responses maintained over 12 months in ...
The mRNA technology behind coronavirus vaccines is now being used to create bespoke vaccines for cancer patients.
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback